This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Beverly C Langevin: Innovator in Pharmaceutical Chemistry
Introduction
Beverly C Langevin is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.
Latest Patents
Langevin holds a patent for "Fumarate salts of a histamine H3 receptor antagonist." This patent relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide. The disclosure includes pharmaceutical compositions, processes for making these compounds, and methods of use.
Career Highlights
Beverly Langevin is currently employed at Sanofi, a leading global biopharmaceutical company. Her work focuses on advancing pharmaceutical innovations that can improve patient outcomes.
Collaborations
Throughout her career, Langevin has collaborated with esteemed colleagues, including Robert Allan Farr and Dinubhai H Shah. These partnerships have contributed to her success in the field.
Conclusion
Beverly C Langevin is a pioneering inventor whose work in pharmaceutical chemistry continues to impact the industry positively. Her innovative contributions and collaborations highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile